Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas - Wikidata - awgldk - TriplyDB

Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas

Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas

http://www.wikidata.org/entity/Q36409237

about

Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells.The role of TWIST, SERPINB5, and SERPIN1 genes in uterine leiomyomas.Recent Advances in Uterine Fibroid Etiology.Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.The androgen receptor mediates antiapoptotic function in myometrial cells An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.Matrix production and remodeling as therapeutic targets for uterine leiomyoma Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma The role of progesterone signaling in the pathogenesis of uterine leiomyoma Cadmium and proliferation in human uterine leiomyoma cells: evidence of a role for EGFR/MAPK pathways but not classical estrogen receptor pathways Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy An essential role of p27 downregulation in fenvalerate-induced cell growth in human uterine leiomyoma and smooth muscle cells.Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells.Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling.Molecular mechanism underlying Akt activation in zinc-induced cardioprotection.Progesterone receptor action in leiomyoma and endometrial cancer.PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes PTEN & LKB1 in human uterine leiomyomas.PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update.Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas.Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis.Role of c-Met in cancer: emphasis on lung cancer.Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo.

P2860

Q24567733-50ABA1DD-DC5E-42B6-99CE-36DC13B90507 Q28487526-344002B1-545C-4C85-AFA1-545761AB8EFB Q29040166-F2466B25-9D0B-4054-BADA-9B007C050CAD Q30875270-87859CAD-EEE6-4B0B-B906-35C33478017F Q33811879-AC4D275F-0B08-49EE-B900-E5856F4BA552 Q33852886-3F37D034-8D63-452D-B739-D18F934DF278 Q33964731-EF3DAEA4-13C0-4F2D-AF58-9619C5529C79 Q34007815-13B9FC59-30E9-49E4-BFE1-0E2BB1C5DDF8 Q34117371-48937A2E-E8CA-4B18-AD3E-88745812C39E Q34195881-5D4A518D-7917-4329-A37D-22B1FD95DFF6 Q34494731-3D29E6C2-D957-499C-94A4-34CCA914CAB0 Q35244896-D3F95983-14CE-4951-B77D-3F103BCE9121 Q35249360-7C3FDB9D-E99A-40BE-A13C-09B452F67182 Q35256471-FD779A56-769F-4B3E-A3EF-865F6D6D778C Q35328276-E57FDBB8-3057-4D0F-913E-8376A70F5F2B Q35855640-9BE95FC4-C603-4E16-8250-428EFD10868C Q36312422-EF0F059A-17E7-4D14-9443-7F6E2B381B25 Q36326856-ADF311F3-4C37-48DA-8B3E-651AE9FBC7D8 Q36723027-FC7C6BB4-81FE-47F6-8457-2236ECE83619 Q37218723-51C4CD4D-BDEF-40A8-94B4-BB1E5B790103 Q37224240-73D429E7-29DE-42D8-A380-8E3351ACCD92 Q37298300-15B073DB-CE25-4334-9A9F-B4BD73CED740 Q37338412-5C9543E4-053A-462B-81E1-454FA47500AC Q37367677-1B55ED9F-2BC8-4628-852F-CCECA79A8E92 Q37931976-39A86FE3-78FF-47F2-A181-C92AFF4A5846 Q38014487-66F8FEB8-42BA-400C-A210-7055C458558B Q38792320-A4F4961A-7D29-43DD-A387-D10D27128746 Q39369473-2513B157-BFC9-44AE-8A05-6E4CC3B6B28F Q39839983-B6A55F31-AD68-41EA-8617-532DF78B65E0 Q41660259-D56D1C78-6070-4A13-8E30-F55A2217A69C Q47119285-F54AF434-79DD-44B2-AE5D-FE29C3DEB459 Q52691932-770351CF-ED72-42E3-89D1-70FDB59C9400

P2860

Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas

http://www.wikidata.org/entity/Q36409237

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Differential expression of rec ...... on in human uterine leiomyomas

@ast

Differential expression of rec ...... on in human uterine leiomyomas

@en

type

label

Differential expression of rec ...... on in human uterine leiomyomas

@ast

Differential expression of rec ...... on in human uterine leiomyomas

@en

prefLabel

Differential expression of rec ...... on in human uterine leiomyomas

@ast

Differential expression of rec ...... on in human uterine leiomyomas

@en

P1433

Q36409237-5FD91B25-013F-49B8-8D38-05612DF56B6E

P1476

Q36409237-C9DA6413-377D-46AF-9B1B-D44C9849248E

P2093

Q36409237-3D233F48-6828-4B96-85C4-9BDCDC00D816

Q36409237-4957E871-9B3D-4012-8A86-C195668D2403

Q36409237-500CDCB8-1636-443E-BC33-9E89AFD3FDB9

Q36409237-5061CD5D-566C-4A65-B63F-64DD67A3DDFC

Q36409237-513151C3-E0FF-4FA9-B479-2A2F4BB3B67C

Q36409237-A8EF4E06-B7AE-4246-8C85-E483005E8692

Q36409237-C2746FC1-7DE3-4342-8A3D-920C3705AD6E

Q36409237-F0629CE2-7A49-4B33-94DE-B6FCDD9D5634

Q36409237-F6C97D42-6870-40E9-AB53-825F5AED1B9D

Q36409237-F91C8158-81DE-474B-B39E-5E86CBC98129

P2860

Q36409237-05212BE5-568F-47B1-8367-0E683BB36DBC

Q36409237-076505A2-A7F1-410C-9FCC-EF7900BE9BFB

Q36409237-0A80EF06-E6F0-4431-B052-C00972E94E86

Q36409237-24ADE7FC-0C1E-45CF-A932-3CC3EA184FEF

Q36409237-2BD621FB-4EE1-497D-B110-0767989DD8EE

Q36409237-2E52A1F8-A134-4EBA-A3F5-BD76A909AD86

Q36409237-30CF8F4E-05C9-4666-82CC-F52C305FE99C

Q36409237-389E1E63-AB74-440C-A1F9-15E7882AD5AC

Q36409237-44474B99-ADBB-4A26-9902-A1D4E7558154

Q36409237-47F921B7-3941-4A11-99AB-5C11E7957201

P2888

Q36409237-8AE14A63-D90D-4955-9D39-E8EA304B93D9

P304

Q36409237-184E6F3A-67CD-4007-9DD6-E955C639B7C4

P31

Q36409237-0F2CF308-B8E1-4194-A309-69B69642D7B0

P356

Q36409237-6FCA8161-66AC-4E31-8763-CE19FD6ADA3E

P407

Q36409237-5E3134FC-F276-4194-BDBA-68FE73EA27AA

P433

Q36409237-B2A13FC2-B3DD-41FF-8CBE-DE061D5C43AC

P478

Q36409237-9766DB49-1904-42B0-8C32-02FB16C529F5

P577

Q36409237-CFC89CC2-9116-4950-AD83-394F8F389E28

P6179

Q36409237-A00134F5-A84B-4A74-BB1E-B0244FA70B98

P698

Q36409237-D244D376-82CA-4A8D-9F77-C553D6891B82

P932

Q36409237-331C21C0-492F-48D3-B9EA-EFD0709D39C8

P356

P1433

Molecular Medicine

P1476

Differential expression of rec ...... on in human uterine leiomyomas

@en

P2093

Carol D Swartz

http://www.w3.org/2001/XMLSchema#string

Darlene Dixon

http://www.w3.org/2001/XMLSchema#string

Grace E Kissling

http://www.w3.org/2001/XMLSchema#string

Hong He

http://www.w3.org/2001/XMLSchema#string

Katrin Saile

http://www.w3.org/2001/XMLSchema#string

Linda Yu

http://www.w3.org/2001/XMLSchema#string

Shantelle Lucas

http://www.w3.org/2001/XMLSchema#string

Stanley J Robboy

http://www.w3.org/2001/XMLSchema#string

Xiaolin Zheng

http://www.w3.org/2001/XMLSchema#string

Xudong Di

http://www.w3.org/2001/XMLSchema#string

P2860

Etiology and pathogenesis of uterine leiomyomas: a review

Cell signaling by receptor tyrosine kinases

Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology

Uterine myomas: an overview of development, clinical features, and management.

Epidemiology of myomas

The IGFI receptor gene: a molecular target for disrupted transcription factors.

Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.

Regulation of IGF-I receptor signaling in tumor cells.

Tyrosine kinase receptors as attractive targets of cancer therapy.

IGF-I receptor, cell-cell adhesion, tumour development and progression.

P2888

P304

264-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2119/2007-00101.YU

http://www.w3.org/2001/XMLSchema#string

P407

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1068965043

http://www.w3.org/2001/XMLSchema#string

P698

18231572

http://www.w3.org/2001/XMLSchema#string

P932

2215764

http://www.w3.org/2001/XMLSchema#string